The time-dependent serial gene response to zeocin treatment involves caspase-dependent apoptosis in HeLa cells

Microbiology and Immunology

Volumn 49, Issue 4, 2005, Pages 331-342

  Hwang, Jooyeon ^a   Kim, Young Youl ^a   Huh, Sungjin ^a   Shim, Junghee ^a   Park, Chan ^a   Kimm, Kuchan ^a   Choi, Dong Kug ^b,c   Park, Tae Kyu ^b   Kim, Soonhag ^a  

^a National Genome Research Institute   (South Korea)

^b Konkuk University   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Apoptosis; Caspase; cDNA chip; Gene expression; HeLa cell; Zeocin

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; CASPASE; CYTOCHROME C; DAXX PROTEIN; FAS ANTIGEN; PHLEOMYCIN; PROTEIN; PROTEIN BCL XL; PROTEIN BID; PROTEIN CASP; PROTEIN ENDOG; PROTEIN MDM2; PROTEIN P53; RNA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; ZEOCIN;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG CYTOTOXICITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GYNECOLOGIC CANCER; HELA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; UNINDEXED SEQUENCE; UPREGULATION; UTERINE CERVIX CANCER;

EID: 18244371674     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2005.tb03737.x     Document Type: Article

References (36)

1. Allday, M.J., Inman, G.J., Crawford, D.H., and Farrell, P.J. 1995. DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. EMBO J. 14: 4994-5005.
2. Alvis, B., and Jaak, V. 2000. Gene expression data analysis. FEBS Lett. 480: 17-24.
3. Andrzej, S., Marcin, K., and Jerzy, K. 2001. Does the anti-tumor cyclopropylpyrroloindole antibiotic CC-1065 cross-link DNA in tumor cells? Biochem. Pharmacol. 61: 67-72.
4. Canman, C.E., Gilmer, T.M., Coutts, S.B., and Kastan, M.B. 1995. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9: 600-611.
5. Calmels, T., Parriche, M., Burand, H., and Tiraby, G. 1991. High efficiency transformation of Tolypocladium geodes conidiospores to phleomycin resistance. Curr. Genet. 20: 309-314.
6. Chaudhry, M.A., Lewis, A.C., McKenna, W.G., and Ruth, J.M. 2003. Gene expression profile of human cells irradiated in G1 and G2 phases of cell cycle. Cancer Lett. 195: 221-233.
7. David, R.G., Jennifer, D.L., Francois, V., Karina, L.J., and Alfons, L. 2001. Mitochondrial cytochrome c release is caspase-dependent and does not involve mitochondrial permeability transition in didemnin B-induced apoptosis. Oncogene 20: 4085-4094.
8. Dimitrios, B., and Carlos, M.A. 2000. Cell-cycle regulation in immunity, tolerance and autoimmunity. Immunol. Today 21: 551-554.
9. Drocourt, D., Calmels, T.P., Reynes, J.P., Baron, M., and Tiraby, G. 1990. Cassettes of the Streptoalloteichus hindustanus ble gene for transformation of lower and higher eukaryotes to phleomycin resistanse. Nucleic Acids Res. 18: 4009.
10. Duggan, D.J., Michael, B., Yidong, C., Paul, M., and Jeffrey, M.T. 1999. Expression profiling using cDNA microarrays. Nat. Genet. 21: 10-14.
11. Ganesh, C.J., and Vijayashree, N. 2000. Effect of doxorubicin in cell survival and micronuclei formation in HeLa cells exposed to different doses of gamma-radiation. Strahlenther. Onkologie 176: 422-428.
12. Harbour, J.W., and Dean, D.C. 2000. Rb function in cell-cycle regulation and apoptosis. Nature Cell Biol. 2: 65-67.
13. Harrington, C.A., Carsten, R., and Jacques, R. 2000. Monitoring gene expression using DNA microarrays. Curr. Opin. Microbiol. 3: 285-291.
14. Israels, E.D., and Israels, L.G. 2000. The cell cycle. The Oncologyst 5: 510-513.
15. Jiang, L., Lee, J.M., and Jeffrey, A.J. 2002. Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells. J. Biol. Chem. 277: 388-394.
16. Joe, W.G., and Colin, C. 2000. Genome changes and gene expression in human solid tumors. Carcinogenesis 21: 443-452.
17. Jung, B.H., Park, C., Kim, H.R., and Park, M.R. 2002. Arsenic trioxide induces apoptosis of HL-60 cells via activation of intrinsic caspase protease with mitochondrial dysfunction. Cancer Res. Treat. 34: 308-315.
18. Karine, F.F., and Kroemer, G. 2001. Organelle-specific initiation of cell death pathways. Nature Cell Biol. 3: 255-259.
19. Kazuyasu, S., Julio, E.H., Saito, S., Toru, M., Michael, B., Alex, V., Carl, W.A., and Ettore, A. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12: 2831-2841.
20. Kim, B.C., Baik, D.J., and Chung, H.S. 1995. Effect of adriamycin in gastric chief cell of hamster. J. Kor. Cancer 27: 184-194.
21. Kim, J.H., Chin, B.R., Kim, S.Y., Kim, J.R., and Baek, S.H. 2003. Differential sensitivity of taxol-induced apoptosis in U2OS and SaOS2 osteogenic sarcoma cells. Cancer Res. Treat. 35: 148-153.
22. Kwak, Y.I., Cheon, Y.K., Kang, Y.K., Lee, S.N., and Kang, T.W. 1997. VACOP-B (Etoposide/Doxorubicin/Cyclophosphamide/Vincristine/Prednisolone/ Bleomycin) combination chemotherapy for the treatment of intermediate and high grade non-Hodgkin's lymphoma. J. Kor. Cancer 29: 146-159.
23. Lee, J.S., Jung, J.J., Lee, S.T., and Park, C.S. 2001. Apoptosis in renal cell carcinoma: correlation to apoptosis-related genes and cell proliferation, and its prognostic significance. J. Kor. Cancer Assoc. 33: 9-15.
24. Lim, H.K., Lee, M.L., Jeon, J.W., Park, S.G., Won, J.H., Baick, S.H., Hong, D.S., and Park, H.S. 1995. Intracavitary therapy with bleomycin for the treatment of malignant pleural and pericardial effusion. J. Kor. Cancer 27: 646-652.
25. Mary, J.E., Lolita, S., and Richard, B.L. 1998. Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2′-deoxyuridin or staurosporine, but not following exposure to etoposide or doxorubicin. Cancer Chemother. Pharmacol. 41: 457-463.
26. Mulsant, P., Tiraby, G., Kallerhoff, J., and Perret, J.S. 1988. Phleomycin resistance as a dominant selectable marker in CHO cells. Cell. Mol. Genet. 10: 243-252.
27. Nicole, C., Margit, S., Christa, Z., Uwe, W., Lukas, H., Jan, S., Sepp, L., and Robert, Z. 2003. Role of p53 in G2/M cell cycle arrest and apoptosis in response to γ-irradiation in ovarian carcinoma cell lines. Int. J. Oncol. 22: 51-57.
28. Nelson, W.G., and Kastan, M.B. 1994. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14: 1815-1823.
29. Pitkane, K., Haapajarvi, T., and Laiho, M. 1998. U.V.C.-induction of p53 activation and accumulation is dependent on cell cycle and pathway involving protein synthesis and phosphorylation. Oncogene 16: 459-469.
30. Ryan, A.J., Squires, S., Strutt, H.L., and Johnson, R.T. 1991. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Res. 19: 3295-3300.
31. Sandra, H., Serguei, K., Tianhong, L., Tamara, G., and Jill, B. 2001. Camptothecin and Zeocin can increase p53 levels during all cell cycle stages. Biochem. Biophys. Res. Commun. 289: 998-1009.
32. Savickiene, J., and Gineitis, A. 2003. 3-Deazauridine triggers dose-dependent apoptosis in myeloid leukemia cells and enhances retinoic acid-induced granulocytic differentiation of HL-60 cells. Int. J. Biochem. Cell Biol. 35: 1482-1494.
33. Shawn, B.B., and Gerald, M.C. 2001. Apoptotic death sensor: an organelle's alter ego? Trends Pharmacol. Sci. 22: 306-315.
34. Thomas, V., Renata, S., Fritz, A., Frischauf, A., and Barbara, K. 2002. Gene expression pattern following photodynamic treatment of the carcinoma cell line A-431 analysed by cDNA arrays. Int. J. Oncol. 21: 1353-1359.
35. Waterman, M.J., Elena, S.S., and Jennifer, L.F. 1998. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19: 175-178.
36. Wang, L., Dun, W., Ping, Q., Asra, M., Marnie, M., Paul, K., Jonathan, R.G., Yaolin, W., Cecil, B.P., and Suxing, L. 2001. Analysis of p53 target genes in the human genome by bioinformatics and microarray approaches. J. Biol. Chem. 276: 43604-43610.